Cheeky's Board!

Stirring the Pot at Duolingo You know what's worse than learning a new language? Finding out the company teaching it might have pulled a few fast ones on the market. That's right, folks, buckle up because Duolingo (NASDAQ: DUOL) is in hot water with a class action lawsuit hanging over its head, like a cloud of bad grammar questions. What's Up with the Lawsuit? This isn't...

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Stepping Up For Better Health You don't see this kind of news getting plastered across the financial pages much—the human side of health. EliHealth Initiative's making strides in a realm many don’t even want to openly discuss: bladder leaks in women. Sounds unglamorous, maybe, but for millions, it's a daily ordeal. Slapping on pads and plotting bathroom routes? That's...

Two Forces Colliding in Specialty Care There's a new dynamic duo in town, and they're set to shake up the specialty practice world. Marvix AI, with its cutting-edge clinical documentation AI, and Unlimited Systems, a powerhouse in revenue cycle management, have teamed up in a way that promises to streamline and optimize the specialty practice workflow substantially....

You know, there's a gold rush happening right now, and it's not for your traditional bullion. It's vitamins, minerals, and all that shiny array of supplements making waves in the market. By 2031, we're talking about a $299.57 billion industry, fueled by a hefty 7.7% CAGR. What's cooking here? Let's delve deeper, my friend. Asia Pacific: A Rising Star Over in the Asia...

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Human Milk-Derived Antibodies: The New Vanguard Out of the blue, here we are talking about human milk-derived antibodies as an answer to the pesky scourge of respiratory viruses. Lactiga US, Inc. has unfolded research that might reshape how we perceive treatments for those with compromised immune systems. Their daring leap into science, backed by McMaster University,...

Breaking Down Newmark's Latest Numbers Ah, Newmark—stepping up again with their quarterly results, and boy, it was nothing short of a spectacle. They just rolled out their third-quarter financials for 2026, and numbers don't lie; they're strutting with $3.7 billion in revenue over the past twelve months. Now, if that doesn't make the investors grin from ear to ear, I...

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

PharmaTher's Roadmap to Ketamine Commercialization PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a pioneering specialty pharmaceutical firm, is steering its focus towards the development and commercialization of ketamine-based therapies. The Company has carved out an impressive path for itself as it aspires to lead in unlocking the...

The Rise of AI Governance in a Chaotic Landscape Here we are, on the cusp of a tech revolution where regulations are starting to tighten around AI like a vise. You remember those wild days back during the dot-com boom, right? Everyone was scrambling to cash in on tech, while the ground rules were still being drawn up. Well, history's repeating itself—only this time,...

Parsons Corporation's Upcoming Conference Presentation Parsons Corporation will soon take the stage at a significant financial event known as the Raymond James 46th Annual Institutional Investors Conference. This prestigious conference is an excellent opportunity for the company to engage with investors and provide insights into its strategic direction. Featured Speakers...

Revolutionizing Mud Pan Cleaning with Innovative Design Meet a groundbreaking solution for home renovation enthusiasts and professionals alike—an inventive tool designed specifically for cleaning mud pans efficiently and effectively. This innovative product stems from the extensive experience of a skilled drywall finisher who spent 40 years in the industry, identifying...

Brookfield Asset Management Achieves New Heights with BAM Stock Brookfield Asset Management Inc (TSX: BAM) recently celebrated a major milestone as its stock reached an impressive 52-week high of $47.45. This achievement demonstrates the company’s strong growth trajectory and effective strategies in place. Investors are showing increased confidence in BAM’s unique...